Bottom line
LYFAX vs PJP: the short answer
LYFAX (AlphaCentric Life Sciences and Healthcare Fund) and PJP (Invesco Pharmaceuticals ETF) are both mutual funds.
PJP is cheaper at 0.58% vs 1.66% — a difference of $108 a year per $10,000 invested.
Over five years, PJP returned +9.0% a year vs +4.1% for LYFAX.
LYFAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
LYFAX vs PJP side by side
| LYFAX | PJP | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Mutual | Invesco |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.66% | 0.58% |
| Annual cost per $10k | $166 | $58 |
| 10-yr cost on $10k (prospectus) | $3,039 | $726 |
| Max front load | 5.75% | None |
| 12b-1 fee | 0.25% | — |
| 1-yr return | +20.6% | +27.9% |
| 5-yr return (annualized) | +4.1% | +9.0% |
| 10-yr return (annualized) | — | +5.1% |
| Best quarter | +27.5% | +18.1% |
| Worst quarter | −11.9% | −14.8% |
| Net assets (fund) | $46.6M | $472.1M |
| Number of holdings | 62 | 33 |
| Portfolio turnover | 107% | 36% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | LYFAX | PJP | Difference |
|---|---|---|---|
| 2025 | +27.9% | +27.9% | −0.0% |
| 2024 | −0.4% | +9.7% | −10.2% |
| 2023 | +6.9% | −2.2% | +9.1% |
| 2022 | −1.1% | −2.0% | +1.0% |
| 2021 | −3.6% | +14.5% | −18.1% |
| 2020 | +54.4% | +11.2% | +43.3% |
Source: Fund prospectus bar charts
Holdings overlap
5 of LYFAX's top 25 holdings also appear in PJP's top 25.
| Holding | LYFAX | PJP |
|---|---|---|
| Gilead Sciences Inc | 5.53% | 4.53% |
| Abbvie Inc | 1.95% | 5.48% |
| Jazz Pharmaceuticals Plc | 1.87% | 2.79% |
| Amgen Inc | 1.83% | 5.33% |
| Biogen Inc | 1.80% | 2.75% |
Source: SEC Form N-PORT
LYFAX top 10
- Gilead Sciences Inc — 5.53%
- Vertex Pharmaceuticals Inc — 5.33%
- Astrazeneca Plc — 4.63%
- First American Funds Inc — 4.26%
- Roivant Sciences Ltd — 3.67%
- Argenx Se — 3.59%
- Neurocrine Biosciences Inc — 3.51%
- Incyte Corp — 3.51%
- Axsome Therapeutics Inc — 3.43%
- Apogee Therapeutics Inc — 3.28%
PJP top 10
- Invesco Private Prime Fund — 7.93%
- Abbott Laboratories — 5.67%
- AbbVie Inc. — 5.48%
- Amgen Inc. — 5.33%
- Johnson & Johnson — 5.18%
- Merck & Co., Inc. — 5.06%
- Eli Lilly and Co. — 5.02%
- Corcept Therapeutics Inc. — 4.96%
- Gilead Sciences, Inc. — 4.53%
- Pfizer Inc. — 4.50%
FAQ
What is the difference between LYFAX and PJP?
Which is cheaper, LYFAX or PJP?
Should I own both LYFAX and PJP?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.